GO and KEGG enrichment analysis results showed that the therapeutic targets of SC for diseases mainly enriched in Bladder cancer, Lipid and atherosclerosis, AGE-RAGE signaling pathway, Kaposi sarcoma-associated herpesvirus infection, IL-17 signaling pathway, Hepatitis C, Human cytomegalovirus infection, Estrogen signaling pathway, TNF signaling pathway, and breast cancer. This evidence concerns the gene IL17A and urinary bladder carcinoma.